KRMD · KORU Medical Systems, Inc.

0001161697-26-000108

Summary

KORU Medical delivered solid revenue growth of 22.1% to $11.8M with narrowing losses, reflecting improved operating leverage from higher volumes despite gross margin pressure from production costs and tariffs.

Key takeaways

Revenue increased 22.1% to $11.8M from $9.6M, driven by higher international pump and consumable volumes from EU PFS conversions and domestic consumable growth from new patient starts.
Gross profit rose 19.6% to $7.2M on volume expansion, though margin declined to 61.5% due to production run timing and tariff charges, offset by favorable sales mix.
Operating loss narrowed 30.5% to -$864.9K as revenue gains outpaced expense growth, improving operating margin to -7.4%.
Net loss improved 30.8% to -$807.1K from -$1.2M, with diluted EPS of -$0.02 versus $0.03 prior year.
Operating cash flow turned positive at $14.7K from -$237K, supported by working capital management amid principal outflows for inventory, R&D, and SG&A.

Full analysis

Operating income improved to a loss of $864.9 thousand, a 30.5% reduction from $1.2 million last year, as revenue expansion outpaced operating expenses. This yielded an operating margin of -7.4%, signaling better leverage. Net income followed suit, narrowing 30.8% to a $807.1 thousand loss, with diluted EPS at -$0.02 compared to $0.03 profit previously.